The estimated Net Worth of Krista Fogarty is at least $49 Mille dollars as of 17 May 2022. Ms Fogarty owns over 12,500 units of Lipocine Inc stock worth over $49,000 and over the last 3 years she sold LPCN stock worth over $0.
Ms has made over 1 trades of the Lipocine Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently she bought 12,500 units of LPCN stock worth $10,750 on 17 May 2022.
The largest trade she's ever made was buying 12,500 units of Lipocine Inc stock on 17 May 2022 worth over $10,750. On average, Ms trades about 4,167 units every 0 days since 2022. As of 17 May 2022 she still owns at least 12,500 units of Lipocine Inc stock.
You can see the complete history of Ms Fogarty stock trades at the bottom of the page.
Krista Fogarty is the Principal Accounting Officer & Corp. Controller at Lipocine Inc.
Ms Fogarty is 53, she's been the Principal Accounting Officer & Corp. Controller of Lipocine Inc since . There are 7 older and 5 younger executives at Lipocine Inc. The oldest executive at Lipocine Inc is Dr. Mahesh V. Patel Ph.D., 64, who is the Co-Founder, Interim Principal Financial Officer, Chairman, Pres & CEO.
Krista's mailing address filed with the SEC is 675 ARAPEEN DRIVE, SUITE 202, , SALT LAKE CITY, UT, 84108.
Over the last 11 years, insiders at Lipocine Inc have traded over $9,045 worth of Lipocine Inc stock and bought 890,945 units worth $696,169 . The most active insiders traders include Mahesh V. Patel, John W. Higuchi e Morgan R Brown. On average, Lipocine Inc executives and independent directors trade stock every 72 days with the average trade being worth of $148,846. The most recent stock trade was executed by Mahesh V. Patel on 25 May 2023, trading 8,706 units of LPCN stock currently worth $43,791.
lipocine inc., a specialty pharmaceutical company, develops and commercializes pharmaceutical products. the company develops drugs based on hydroance, a drug delivery technology. it primarily focuses on developing oral versions of several hormones for use in men and women health. the company’s lipid-based technology platform offers non-invasive delivery solutions for small polar organics and macromolecules. it also offers custom drugs for pharmaceutical/biotechnology companies. lipocine inc. was founded in 1997 and is headquartered in salt lake city, utah.
Lipocine Inc executives and other stock owners filed with the SEC include: